Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma, Kaposi 2Sarcoma 2Ovarian Neoplasms 2Multiple Myeloma 2Melanoma 2Hemangioma, Capillary 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Lymphatic Metastasis 1Liver Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Nivolumab 5Specimen Handling 3Magnetic Resonance Spectroscopy 3pomalidomide 2pembrolizumab 2liposomal doxorubicin 2Propranolol 2lenvatinib 1ixazomib 1cabozantinib 1abemaciclib 1Paclitaxel 1Nelfinavir 1Ipilimumab 1Everolimus 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Kaposi × Propranolol × 1 year × Clear all
NCT06445166 2026-04-06

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine

Phase 2 Recruiting
25 enrolled
Sarcoma

Sarcoma, Sarcoma, Kaposi

NCT05797662 2026-01-23

A Study of Propranolol to Treat Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Not yet recruiting
25 enrolled
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡